Erech Finance Cahalacha (XTAE:EFNC-M) EBIT : ₪-12.73 Mil (TTM As of Jun. 2024)

View and export this data going back to 2010. Start your Free Trial

What is Erech Finance Cahalacha EBIT?

Erech Finance Cahalacha's earnings before interest and taxes (EBIT) for the six months ended in Jun. 2024 was ₪-2.67 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Jun. 2024 was ₪-12.73 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Erech Finance Cahalacha's annualized ROC % for the quarter that ended in Jun. 2024 was -26.51%. Erech Finance Cahalacha's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2024 was -259.10%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Erech Finance Cahalacha's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2024 was -59.94%.

Erech Finance Cahalacha EBIT Historical Data

The historical data trend for Erech Finance Cahalacha's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Erech Finance Cahalacha EBIT Chart

Erech Finance Cahalacha Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT

Get a 7-Day Free Trial

-3.88

0.37

2.97

-26.44

-17.48

Erech Finance Cahalacha Semi-Annual Data
	Dec13	Dec14	Dec15	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
EBIT	Get a 7-Day Free Trial														3.23	-29.67	-7.42	-10.06	-2.67

Competitive Comparison of Erech Finance Cahalacha's EBIT

For the Medical Devices subindustry, Erech Finance Cahalacha's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Erech Finance Cahalacha's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Erech Finance Cahalacha's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Erech Finance Cahalacha's EV-to-EBIT falls into.

Save Embed

;

Save Embed

;

Erech Finance Cahalacha EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₪-12.73 Mil.

Erech Finance Cahalacha (XTAE:EFNC-M) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Erech Finance Cahalacha's annualized ROC % for the quarter that ended in Jun. 2024 is calculated as:

	ROC % (Q: Jun. 2024 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Dec. 2023 )	+	Invested Capital (Q: Jun. 2024 ))	/ count )
=	-5.34 * ( 1 - -52.34% )	/	( (28.309	+	33.053)	/ 2 )
=	-8.134956	/	30.681
=	-26.51 %

where

	Invested Capital		(Q: Dec. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	23.472	-	2.142	-	( 1.609	-	max(0, 14.823	-	7.844	+	1.609	))
=	28.309

	Invested Capital		(Q: Jun. 2024 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	19.918	-	2.495	-	( 1.364	-	max(0, 18.909	-	3.279	+	1.364	))
=	33.053

Note: The Operating Income data used here is two times the semi-annual (Jun. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Erech Finance Cahalacha's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2024 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Jun. 2024 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Dec. 2023		Q: Jun. 2024
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	-5.34	/	( ( (0.027 + max(4.065, 0))	+	(0.03 + max(-0.761, 0)) )	/	2 )
=	-5.34	/	( ( 4.092	+	0.03 )	/	2 )
=	-5.34	/	2.061
=	-259.10 %

where Working Capital is:

	Working Capital		(Q: Dec. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(6.235	+	0	+	0)	-	(2.142	+	0	+	0.028)
=	4.065

	Working Capital		(Q: Jun. 2024 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(1.734	+	0	+	0)	-	(2.495	+	0	+	-3.5527136788005E-15)
=	-0.761

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Jun. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Erech Finance Cahalacha's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Jun. 2024 )
	=	-12.728	/	21.235
	=	-59.94 %

Erech Finance Cahalacha EBIT Related Terms

Thank you for viewing the detailed overview of Erech Finance Cahalacha's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Erech Finance Cahalacha Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Erech Finance Cahalacha Ltd (XTAE:EFNC-M) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

Yakov Eliav 5, Downtown, Jerusalem, ISR

Website

http://www.insuline-medical.com

Erech Finance Cahalacha Ltd, formerly Insuline Medical Ltd is a medical device company. It develops & markets technologies to the clinical effectiveness of devices & drugs for the treatment of diabetes. Its products include the InsuPatch device for insulin pump users, & the InsuPad device for injection users. The InsuPad is a company's flagship product.

Erech Finance Cahalacha Headlines

No Headlines